Loading...

UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Joydeep Mukherjee, PhD

Title(s)Assistant Researcher, Neurological Surgery
SchoolSchool of Medicine
Phone415-502-7126
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ohba S, Johannessen TA, Chatla K, Yang X, Pieper RO, Mukherjee J. Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity. Cell Rep. 2020 Apr 14; 31(2):107518. PMID: 32294440.
      View in: PubMed
    2. Ohba S, Murayama K, Kuwahara K, Pareira ES, Nakae S, Nishiyama Y, Adachi K, Yamada S, Sasaki H, Yamamoto N, Abe M, Mukherjee J, Hasegawa M, Pieper RO, Hirose Y. The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas. Neurosurgery. 2019 Dec 13. PMID: 31833548.
      View in: PubMed
    3. Sarkar S, Mukherjee A, Parvin R, Das S, Roy U, Ghosh S, Chaudhuri P, Roychowdhury T, Mukherjee J, Bhattacharya S, Gachhui R. Removal of Pb (II), As (III), and Cr (VI) by nitrogen-starved Papiliotrema laurentii strain RY1. J Basic Microbiol. 2019 Oct; 59(10):1016-1030. PMID: 31430397.
      View in: PubMed
    4. Chen D, Xia S, Wang M, Lin R, Li Y, Mao H, Aguiar M, Famulare CA, Shih AH, Brennan CW, Gao X, Pan Y, Liu S, Fan J, Jin L, Song L, Zhou A, Mukherjee J, Pieper RO, Mishra A, Peng J, Arellano M, Blum WG, Lonial S, Boggon TJ, Levine RL, Chen J. Mutant and Wild-Type Isocitrate Dehydrogenase 1 Share Enhancing Mechanisms Involving Distinct Tyrosine Kinase Cascades in Cancer. Cancer Discov. 2019 06; 9(6):756-777. PMID: 30862724.
      View in: PubMed
    5. Radoul M, Najac C, Viswanath P, Mukherjee J, Kelly M, Gillespie AM, Chaumeil MM, Eriksson P, Delos Santos R, Pieper RO, Ronen SM. HDAC inhibition in glioblastoma monitored by hyperpolarized 13 C MRSI. NMR Biomed. 2019 02; 32(2):e4044. PMID: 30561869.
      View in: PubMed
    6. Bhattacharya S, Bhattacharya S, Gachhui R, Hazra S, Mukherjee J. U32 collagenase from Pseudoalteromonas agarivorans NW4327: Activity, structure, substrate interactions and molecular dynamics simulations. Int J Biol Macromol. 2019 Mar 01; 124:635-650. PMID: 30476512.
      View in: PubMed
    7. Wood MD, Mukherjee J, Pieper RO. Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro. Sci Rep. 2018 04 11; 8(1):5805. PMID: 29643433.
      View in: PubMed
    8. Mukherjee J, Johannessen TC, Ohba S, Chow TT, Jones L, Pandita A, Pieper RO. Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma. Cancer Res. 2018 06 01; 78(11):2966-2977. PMID: 29545335.
      View in: PubMed
    9. Mahansaria R, Dhara A, Saha A, Haldar S, Mukherjee J. Production enhancement and characterization of the polyhydroxyalkanoate produced by Natrinema ajinwuensis (as synonym) = Natrinema altunense strain RM-G10. Int J Biol Macromol. 2018 Feb; 107(Pt B):1480-1490. PMID: 28987801.
      View in: PubMed
    10. Mukherjee J, Chakraborty DP, Guha G, Bose B, Saha SP. Recent Drug Resistant Epilepsy Spectrum in Eastern India. J Epilepsy Res. 2017 Jun; 7(1):39-44. PMID: 28775954.
      View in: PubMed
    11. Ohba S, Mukherjee J, Johannessen TC, Mancini A, Chow TT, Wood M, Jones L, Mazor T, Marshall RE, Viswanath P, Walsh KM, Perry A, Bell RJ, Phillips JJ, Costello JF, Ronen SM, Pieper RO. Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process. Cancer Res. 2016 11 15; 76(22):6680-6689. PMID: 27758882.
      View in: PubMed
    12. Johannessen TA, Mukherjee J, Viswanath P, Ohba S, Ronen SM, Bjerkvig R, Pieper RO. Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis. Mol Cancer Res. 2016 10; 14(10):976-983. PMID: 27430238.
      View in: PubMed
    13. Mukherjee J, Ohba S, See WL, Phillips JJ, Molinaro AM, Pieper RO. PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells. Int J Cancer. 2016 Jul 01; 139(1):99-111. PMID: 26874904.
      View in: PubMed
    14. Park I, Mukherjee J, Ito M, Chaumeil MM, Jalbert LE, Gaensler K, Ronen SM, Nelson SJ, Pieper RO. Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cells. Cancer Res. 2014 Dec 01; 74(23):7115-24. PMID: 25320009.
      View in: PubMed
    15. Ohba S, Mukherjee J, See WL, Pieper RO. Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance. Cancer Res. 2014 Sep 01; 74(17):4836-44. PMID: 25035396.
      View in: PubMed
    16. DeSouza LV, Matta A, Karim Z, Mukherjee J, Wang XS, Krakovska O, Zadeh G, Guha A, Siu KM. Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme. Mol Cancer. 2013 Jul 15; 12:74. PMID: 23855374.
      View in: PubMed
    17. Ito M, Ohba S, Gaensler K, Ronen SM, Mukherjee J, Pieper RO. Early Chk1 phosphorylation is driven by temozolomide-induced, DNA double strand break- and mismatch repair-independent DNA damage. PLoS One. 2013; 8(5):e62351. PMID: 23667469.
      View in: PubMed
    18. Mukherjee J, Phillips JJ, Zheng S, Wiencke J, Ronen SM, Pieper RO. Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma. PLoS One. 2013; 8(2):e57610. PMID: 23451252.
      View in: PubMed
    19. Park I, Hu S, Bok R, Ozawa T, Ito M, Mukherjee J, Phillips JJ, James CD, Pieper RO, Ronen SM, Vigneron DB, Nelson SJ. Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imaging. Magn Reson Med. 2013 Jul; 70(1):33-9. PMID: 22851374.
      View in: PubMed
    20. See WL, Tan IL, Mukherjee J, Nicolaides T, Pieper RO. Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency. Cancer Res. 2012 Jul 01; 72(13):3350-9. PMID: 22573716.
      View in: PubMed
    21. Basu K, Mukherjee J, Law S, Chaudhuri S. Biological response modifiers influence structure function relationship of hematopoietic stem and stromal cells in a mouse model of leukemia. Asian Pac J Cancer Prev. 2012; 13(6):2935-41. PMID: 22938486.
      View in: PubMed
    22. Pramanik A, Sundararaman M, Das S, Ghosh U, Mukherjee J. ISOLATION AND CHARACTERIZATION OF CYANOBACTERIA POSSESSING ANTIMICROBIAL ACTIVITY FROM THE SUNDARBANS, THE WORLD'S LARGEST TIDAL MANGROVE FOREST(1). J Phycol. 2011 Aug; 47(4):731-43. PMID: 27020009.
      View in: PubMed
    23. McLarty K, Moran MD, Scollard DA, Chan C, Sabha N, Mukherjee J, Guha A, McLaurin J, Nitz M, Houle S, Wilson AA, Reilly RM, Vasdev N. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice. Nucl Med Biol. 2011 Oct; 38(7):953-9. PMID: 21982567.
      View in: PubMed
    24. Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, Cairns R, Hawkins C, Guha A. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med. 2011 Feb 14; 208(2):313-26. PMID: 21242296.
      View in: PubMed
    25. Bhola P, Banerjee S, Mukherjee J, Balasubramanium A, Arun V, Karim Z, Burrell K, Croul S, Gutmann DH, Guha A. Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft. Int J Cancer. 2010 Jan 15; 126(2):563-71. PMID: 19634141.
      View in: PubMed
    26. Mukherjee J, DeSouza LV, Micallef J, Karim Z, Croul S, Siu KW, Guha A. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII. Cancer Res. 2009 Nov 15; 69(22):8545-54. PMID: 19903856.
      View in: PubMed
    27. Micallef J, Taccone M, Mukherjee J, Croul S, Busby J, Moran MF, Guha A. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Cancer Res. 2009 Oct 01; 69(19):7548-56. PMID: 19773446.
      View in: PubMed
    28. Mukherjee J, Kamnasaran D, Balasubramaniam A, Radovanovic I, Zadeh G, Kiehl TR, Guha A. Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate). Cancer Res. 2009 Jun 15; 69(12):5099-107. PMID: 19509233.
      View in: PubMed
    29. Harris MA, Yang H, Low BE, Mukherjee J, Mukherje J, Guha A, Bronson RT, Shultz LD, Israel MA, Yun K. Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res. 2008 Dec 15; 68(24):10051-9. PMID: 19074870.
      View in: PubMed
    30. Ghosh A, Mukherjee J, Bhattacharjee M, Sarkar P, Acharya S, Chaudhuri S, Chaudhuri S. The other side of the coin: beneficiary effect of 'oxidative burst' upsurge with T11TS facilitates the elimination of glioma cells. Cell Mol Biol (Noisy-le-grand). 2007 May 30; 53(5):53-62. PMID: 17543233.
      View in: PubMed
    31. Bhattacharjee M, Bose I, Sarkar P, Banerjee C, Dutta S, Ghosh A, Mukherjee J, Acharya S, Goswami S, Mazumdar A, Chaudhuri S, Chaudhuri S. A sequential scanning of the immune efficiency in astrocytoma (Grade I to Grade Iii), meningioma and secondary glioma patients with and without therapeutic scheduling. Cancer Invest. 2006 Aug-Sep; 24(5):502-13. PMID: 16939959.
      View in: PubMed
    32. Mukherjee J, Ghosh A, Ghosh A, Chaudhuri S. ENU administration causes genomic instability along with single nucleotide polymorphisms in p53 during gliomagenesis: T11TS administration demonstrated in vivo apoptosis of these genetically altered tumor cells. Cancer Biol Ther. 2006 Feb; 5(2):156-64. PMID: 16357521.
      View in: PubMed
    33. Mukherjee J, Ghosh A, Sarkar P, Mazumdar M, Banerjee C, Chaudhuri S. Immunotherapy with T11TS / S-LFA-3 specifically induces apoptosis of brain tumor cells by augmenting intracranial immune status. Anticancer Res. 2005 Jul-Aug; 25(4):2905-19. PMID: 16080544.
      View in: PubMed
    34. Mukherjee J, Ghosh A, Sarkar S, Mazumdar M, Sarkar P, Duttagupta AK, Chaudhuri S. T11TS/S-LFA3 induces apoptosis of the brain tumor cells: a new approach to characterise the apoptosis associated genetic changes by arbitrarily primed-PCR. Cancer Lett. 2005 May 10; 222(1):23-38. PMID: 15837538.
      View in: PubMed
    35. Sarkar S, Ghosh A, Dutta S, Roy RU, Begum Z, Mukherjee J, Chaudhuri S, Chaudhuri S. Sheep erythrocyte demonstrated better effect than IL-2 and IFN-gamma as biological response modifier against glioma in experimental model. Indian J Exp Biol. 2005 May; 43(5):414-9. PMID: 15900905.
      View in: PubMed
    36. Guha A, Mukherjee J. Advances in the biology of astrocytomas. Curr Opin Neurol. 2004 Dec; 17(6):655-62. PMID: 15542973.
      View in: PubMed
    37. Sarkar S, Ghosh A, Mukherjee J, Chaudhuri S, Chaudhuri S. CD2-SLFA3/T11TS interaction facilitates immune activation and glioma regression by apoptosis. Cancer Biol Ther. 2004 Nov; 3(11):1121-8. PMID: 15467439.
      View in: PubMed
    38. Ghosh A, Sarkar S, Begum Z, Dutta S, Mukherjee J, Bhattacharjee M, Sarkar P, Banerjee C, Mandal M, Mazumdar A, Bhattacharjee MK, Chaudhuri S, Chaudhuri S. The first cross sectional survey on intracranial malignancy in Kolkata, India: reflection of the state of the art in southern West Bengal. Asian Pac J Cancer Prev. 2004 Jul-Sep; 5(3):259-67. PMID: 15373704.
      View in: PubMed
    39. Mukherjee J, Sarkar S, Ghosh A, Duttagupta AK, Chaudhuri S, Chaudhuri S. Immunotherapeutic effects of T11TS/S-LFA3 against nitrosocompound mediated neural genotoxicity. Toxicol Lett. 2004 May 02; 150(3):239-57. PMID: 15110076.
      View in: PubMed
    40. Begum Z, Ghosh A, Sarkar S, Mukherjee J, Mazumdar M, Sarkar P, Chaudhuri S. Documentation of immune profile of microglia through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3. Glycoconj J. 2004; 20(9):515-23. PMID: 15454689.
      View in: PubMed
    41. Sarkar P, Mukherjee J, Ghosh A, Bhattacharjee M, Mahato S, Chakraborty A, Mondal M, Banerjee C, Chaudhuri S. A comparative analysis of immunorestoration and recovery with conventional and immunotherapeutic protocols in canine generalized demodicosis: a newer insight of immunotherapeutic efficacy of T11TS. Immunol Invest. 2004; 33(4):453-68. PMID: 15624702.
      View in: PubMed
    42. Begum Z, Sarkar S, Mukherjee J, Ghosh A, Chaudhuri S, Chaudhuri S. Evaluation of anti-tumor property of specific and non-specific BRMs in experimental gioma by assessing the microglial cell functional and phenotypic modulations. Cancer Biol Ther. 2003 Jul-Aug; 2(4):356-63. PMID: 14508105.
      View in: PubMed
    43. Mukherjee J, Dutta S, Sarkar S, Begum Z, Ghosh A, Chaudhuri S, Chaudhuri S. Preclinical Changes in Immunoreactivity and Cellular Architecture during the Progressive Development of Intracranial Neoplasms and an Immunotherapeutic Schedule with a Novel Biological Response Modifier, the T11TS / S-LFA3. Asian Pac J Cancer Prev. 2002; 3(4):325-337. PMID: 12716291.
      View in: PubMed